Get details about our clinical trials that are currently enrolling patients.View Clinical Trials
As one of the world’s largest cancer research centers, MD Anderson is leading the investigation into new methods of carcinoid tumor diagnosis and treatment. For instance, our researchers are studying carcinoid tumors on a molecular basis to try to find a cause.
Our status as a premier research center means we can offer clinical trials (research studies) of new treatments for carcinoid tumors. MD Anderson researchers have led the development of novel treatment strategies, including targeting of mTOR (a protein) and angiogenesis (growth of new blood vessels) in neuroendocrine tumors (including carcinoid tumors). MD Anderson researchers were involved from proof-of-concept single institution phase II to multi-national phase III studies.
Understanding a disease is the first step toward finding the right care. Get the facts about carcinoid tumors, including the different types, how it starts and who’s at risk.
did you know?
Carcinoid tumors are a type of neuroendocrine tumor, which typically develop in the digestive system.
BY Mary Powell
August 22, 2013
I labeled the daily emails from our March trip to MD Anderson for my brother’s stem cell transplant “our adventure,” and that’s exactly what it turned out to be.
I was excited to be a stem cell donor for my brother, Dan, who has leukemia. But when the doctors performed a chest x-ray, they discovered a questionable spot on my lung. We hoped it was nothing, but scheduled a CT scan to make sure.
The scan revealed...